The immobilization of recombinant human tropoelastin on metals using a plasma-activated coating to improve the biocompatibility of coronary stents

Biomaterials

Volumn 31, Issue 32, 2010, Pages 8332-8340

  Waterhouse, Anna ^a   Yin, Yongbai ^a   Wise, Steven G ^b   Bax, Daniel V ^a   McKenzie, David R ^a   Bilek, Marcela M M ^a   Weiss, Anthony S ^a   Ng, Martin K C ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b HEART RESEARCH INSTITUTE   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Biocompatibility; Elastin; Plasma deposition; Stainless steel; Stent; Thrombogenicity

Indexed keywords

316L SS; CELL INTERACTION; CLINICAL EFFICACY; COATING PROPERTIES; CORONARY STENTS; COVALENTLY BOUND; ELASTIN; ENDOVASCULAR STENTS; HEMOCOMPATIBILITY; HUMAN BLOODS; IN-VIVO; MECHANICAL DURABILITY; METAL ALLOYS; PLATELET ACTIVATION; PROTEIN BINDING; SOLUBLE P; STENT; THROMBOGENICITY; TROPOELASTIN; VAPOR COMPOSITION; VASCULAR CELLS;

ARGON; BIOCHEMISTRY; BIOCOMPATIBILITY; BIOMECHANICS; CELL PROLIFERATION; COATINGS; ENDOTHELIAL CELLS; GLYCOPROTEINS; NITROGEN PLASMA; OPTIMIZATION; OXYGEN; PLASMA DEPOSITION; SELF ASSEMBLY; STAINLESS STEEL; SURFACE PROPERTIES;

MECHANICAL PROPERTIES;

ALLOY; ARGON; HYDROGEN; METAL; NITROGEN; OXYGEN; PADGEM PROTEIN; RECOMBINANT PROTEIN; TROPOELASTIN;

ARTICLE; BIOCOMPATIBILITY; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY STENT; COVALENT BOND; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYDROPHILICITY; MALE; MATERIAL COATING; MECHANICS; NORMAL HUMAN; PLASMA ACTIVATED COATING; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; SOLUBILITY; STENT THROMBOSIS; SURFACE PROPERTY; THROMBOCYTE ACTIVATION; THROMBOGENICITY;

CELL LINE; CELL PROLIFERATION; COATED MATERIALS, BIOCOMPATIBLE; HUMANS; IMMOBILIZED PROTEINS; MATERIALS TESTING; METALS; PLATELET ACTIVATION; RECOMBINANT PROTEINS; STENTS; SURFACE PROPERTIES; THROMBOSIS; TROPOELASTIN;

EID: 77956186077     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.07.062     Document Type: Article

References (33)

1. Serruys P.W., Kutryk M.J.B., Ong A.T.L. Coronary-artery stents. N Engl J Med 2006, 354:483-495.
2. Serruys P.W., Strauss B.H., Beatt K.J., Bertrand M.E., Puel J., Rickards A.F., et al. Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med 1991, 324:13-17.
3. Lemesle G., Delhaye C., Bonello L., de Labriolle A., Waksman R., Pichard A. Stent thrombosis in 2008: definition, predictors, prognosis and treatment. Arch Cardiovasc Dis 2008, 101:769-777.
4. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.-A., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007, 115:2344-2351.
5. Cutlip D.E., Baim D.S., Ho K.K.L., Popma J.J., Lansky A.J., Cohen D.J., et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001, 103:1967-1971.
6. Joner M., Finn A.V., Farb A., Mont E.K., Kolodgie F.D., Ladich E., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006, 48:193-202.
7. Pendyala L., Jabara R., Robinson K.A., Chronos N.A. Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing. J Interv Cardiol 2009, 22:37-48.
8. Wiemer M., Butz T., Schmidt W., Schmitz K.-P., Horstkotte D., Langer C. Scanning electron microscopic analysis of different drug eluting stents after failed implantation: from nearly undamaged to major damaged polymers. Catheter Cardiovasc Interv 2009, 75:905-911.
9. Williams D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29:2941-2953.
10. ® - no influence on restenosis or clinical outcome. Eur Heart J 2001, 22:1808-1816.
11. TM endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study. Eur Heart J 2010, 31:1055-1064.
12. Ito S., Ishimaru S., Wilson S.E. Effect of coacervated alpha-elastin on proliferation of vascular smooth muscle and endothelial cells. Angiology 1998, 49:289-297.
13. Karnik S.K., Brooke B.S., Bayes-Genis A., Sorensen L., Wythe J.D., Schwartz R.S., et al. A critical role for elastin signaling in vascular morphogenesis and disease. Development 2003, 130:411-423.
14. Jordan S.W., Chaikof E.L. Novel thromboresistant materials. J Vasc Surg 2007, 45:A104-A115.
15. Martin S.L., Vrhovski B., Weiss A.S. Total synthesis and expression in Escherichia coli of a gene encoding human tropoelastin. Gene 1995, 154:159-166.
16. Yin Y., Bilek M.M.M., McKenzie D.R., Nosworthy N.J., Kondyurin A., Youssef H., et al. Acetylene plasma polymerized surfaces for covalent immobilization of dense bioactive protein monolayers. Surf Coat Technol 2009, 203:1310-1316.
17. Bilek M.M.M., McKenzie D.R. Plasma modified surfaces for covalent immobilization of functional biomolecules in the absence of chemical linkers: towards better biosensors and a new generation of medical implants. Biophys Rev 2010, 2:55-65.
18. Yin Y., Fisher K., Nosworthy N.J., Bax D., Rubanov S., Gong B., et al. Covalently bound biomimetic layers on plasma polymers with graded metallic interfaces for in vivo implants. Plasma Process Polym 2009, 6:658-666.
19. Yin Y., Wise S.G., Nosworthy N.J., Waterhouse A., Bax D.V., Youssef H., et al. Covalent immobilisation of tropoelastin on a plasma deposited interface for enhancement of endothelialisation on metal surfaces. Biomaterials 2009, 30:1675-1681.
20. Ng M.K.C., Nakhla S., Baoutina A., Jessup W., Handelsman D.J., Celermajer D.S. Dehydroepiandrosterone, an adrenal androgen, increases human foam cell formation: a potentially pro-atherogenic effect. J Am Coll Cardiol 2003, 42:1967-1974.
21. Bax D.V., Rodgers U.R., Bilek M.M.M., Weiss A.S. Cell adhesion to tropoelastin is mediated via the C-terminal GRKRK motif and integrin alphaVbeta3. J Biol Chem 2009, 284:28616-28623.
22. Chandler A.B. In vitro thrombotic coagulation of the blood. A method for producing a thrombus. Lab Invest 1958, 7:110-114.
23. Berne R.M., Levy M.N. Cardiovascular physiology 1992, Mosby Year Book, St Louis. 6th ed.
24. Werner C., Maitz M.F., Sperling C. Current strategies towards hemocompatible coatings. J Mater Chem 2007, 17:3376-3384.
25. Hezi-Yamit A., Sullivan C., Wong J., David L., Chen M., Cheng P., et al. Impact of polymer hydrophilicity on biocompatibility: implication for DES polymer design. J Biomed Mater Res A 2009, 90A:133-141.
26. Hemostasis and thrombosis. Basic principles and clinical practice 2006, 437-441. Lippincott Williams & Wilkins, Philadelphia. 5th ed. R.W. Colman, V.J. Marder, A.W. Clowes, J.N. George, S.Z. Goldhaber (Eds.).
27. McKenzie D.R., Muller D., Pailthorpe B.A. Compressive-stress induced formation of thin-film tetrahedral amorphous carbon. Phys Rev Lett 1991, 67:773-776.
28. 3 Hybridization ratio in amorphous carbon from C 1s core-level shifts: X-ray photoelectron spectroscopy and first-principles calculation. Phys Rev B 2001, 65:045101.
29. Seeger J.M., Ingegno M.D., Bigatan E., Klingman N., Amery D., Widenhouse C., et al. Hydrophilic surface modification of metallic endoluminal stents. J Vasc Surg 1995, 22:327-336.
30. Gorbet M.B., Sefton M.V. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004, 25:5681-5703.
31. Schomig A., Neumann F.-J., Kastrati A., Schuhlen H., Blasini R., Hadamitzky M., et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996, 334:1084-1089.
32. Motlagh D., Yang J., Lui K.Y., Webb A.R., Ameer G.A. Hemocompatibility evaluation of poly(glycerol-sebacate) in vitro for vascular tissue engineering. Biomaterials 2006, 27:4315-4324.
33. Palmaz J.C. Intravascular stents: tissue-stent interactions and design considerations. Am J Roentgenol 1993, 160:613-618.